Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:SPNE

SeaSpine (SPNE) Stock Price, News & Analysis

SeaSpine logo

About SeaSpine Stock (NASDAQ:SPNE)

Advanced Chart

Key Stats

Today's Range
$8.43
$9.67
50-Day Range
$7.03
$9.54
52-Week Range
$5.48
$14.23
Volume
1.16 million shs
Average Volume
822,700 shs
Market Capitalization
$354.92 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive SPNE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SeaSpine and its competitors with MarketBeat's FREE daily newsletter.

SPNE Stock News Headlines

The Biggest Night in Brownstone Research History
On Wednesday, August 20, at 8 p.m. ET, Jeff Brown will host what he believes could be the biggest night in Brownstone Research history. He calls it The Hyper Acceleration—a rare market event that’s only happened twice in the last 250 years, each time creating some of the largest tech fortunes ever recorded. Jeff will explain why he believes the U.S. stock market could grow from $19 trillion to $220 trillion by 2030—and why this shift could create opportunities to target stocks with 1,000% profit potential every month. He’ll even reveal two of his favorite stocks, free, that he believes could soar 1,000% or more.
Spine Biologics Market Size to Achieve USD 6.95 Bn by 2033
Q2 2024 Orthofix Medical Inc Earnings Call
See More Headlines

SPNE Stock Analysis - Frequently Asked Questions

SeaSpine Holdings Co. (NASDAQ:SPNE) issued its earnings results on Thursday, October, 28th. The medical equipment provider reported ($0.48) earnings per share for the quarter, missing analysts' consensus estimates of ($0.31) by $0.17. SeaSpine's revenue for the quarter was up 7.5% compared to the same quarter last year.

Based on aggregate information from My MarketBeat watchlists, some other companies that SeaSpine investors own include AbbVie (ABBV), Bristol Myers Squibb (BMY), Gilead Sciences (GILD), Amarin (AMRN), Alphatec (ATEC), Meta Platforms (META) and uniQure (QURE).

Company Calendar

Last Earnings
10/28/2021
Today
8/15/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:SPNE
CIK
1637761
Fax
N/A
Employees
523
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.77)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$54.35 million
Net Margins
-28.22%
Pretax Margin
-28.83%
Return on Equity
-22.16%
Return on Assets
-17.09%

Debt

Debt-to-Equity Ratio
0.09
Current Ratio
3.18
Quick Ratio
1.65

Sales & Book Value

Annual Sales
$191.45 million
Price / Sales
1.85
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$8.57 per share
Price / Book
1.11

Miscellaneous

Outstanding Shares
37,203,000
Free Float
33,736,000
Market Cap
$354.92 million
Optionable
Optionable
Beta
1.31

Social Links

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:SPNE) was last updated on 8/15/2025 by MarketBeat.com Staff
From Our Partners